| Financial Year |
March 31 2023 |
| Monetary Funds |
1,791,433,881.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
83,602,917.36 |
| Accounts Receivable |
1,942,322,437.29 |
| Advances to Suppliers |
246,068,624.06 |
| Other Receivables |
80,697,601.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,360,638,922.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,073,564.00 |
| Other Current Assets |
175,312,651.63 |
| Total Current Assets |
6,740,559,397.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,922,042.04 |
| Long-term Equity Investment |
339,106,122.95 |
| Investment Properties |
196,740,085.84 |
| Fixed Assetes |
2,774,619,502.16 |
| Under-construction Projects |
383,427,813.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
247,162,917.55 |
| R&D expenses |
-- |
| Goodwill |
94,010,439.09 |
| Long-Term Deferred and Prepaid Expenses |
81,139,135.15 |
| Deferred Income Tax Assets |
63,359,781.23 |
| Other Non-Current Assets |
84,411,596.13 |
| Sub-Total of Non-Current Assets |
5,593,705,094.71 |
| Total Assets |
12,334,264,492.25 |
| Short-Term Loans |
2,120,821,302.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
334,560,253.80 |
| Accounts Payable |
1,211,271,878.02 |
| Accounts Received In Advance |
5,294,066.17 |
| Employee Compensation Payable |
81,603,214.09 |
| Taxes Payable |
120,386,006.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
256,645,605.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
107,579,071.26 |
| Other Current Liabilities |
55,697,560.78 |
| Sub-Total of Current Liabilities |
4,452,314,024.88 |
| Long-term Loans |
1,528,011,522.50 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
144,185,811.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,824,606,206.12 |
| Total Liabilities |
6,276,920,231.00 |
| Paid-In Capital(Or Share Stock) |
1,516,736,158.00 |
| Capital Surplus |
288,024,171.13 |
| Surplus Reserve |
725,923,129.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,938,368,982.50 |
| Minority Stockholder's Interest |
428,940,472.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,628,403,789.20 |
| Owner's Equity（Stockholder's Equity） |
6,057,344,261.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,334,264,492.25 |
